Studies on Drug Use Pattern and Cost Efficiency in Upozila Health Complexes in Dhaka Division of Bangladesh

  • H. M. Alamgir Department of Clinical Pharmacy and Pharmacology Faculty of Pharmacy University of Dhaka
  • Muniruddin Ahmed
Keywords: PHC, Primary Health Care, OPD, Out Patient Department, STG, Standard Treatment Guideline, EDL, Essential Drug List, ARI, Acute Respiratory tract Infection, UHC, Upozila Health Complex.


The objective of the study was to investigate the pattern of drug use in public health facilities in Dhaka division of Bangladesh. The results obtained from 600 outpatients of 20 randomly selected Upozila Health Complexes were analyzed with an excel software program. Based on INRUD indicators of rational drug use were obtained from January-December in 2014. Average number of drugs per encounter was 3.  On average the percentage of drugs prescribed by generic name was 49. Antibiotics were prescribed in 44% of prescriptions. 59 % of drugs prescribed appeared on the national essential drug list.  Average consulting and dispensing time were observed to be 2 minutes and 22 seconds respectively. Patients who could repeat the correct drug dose schedule was 36%.  Key drugs available in the health complexes were 51%. The average cost of drugs per encounter was Tk. 236. The average number of encounters with antibiotics per Upozila health complex was 13 and average cost of antibiotics per encounter was found to be Tk. 211. The prevalence of acute respiratory infection, dysentery, diarrhea, scabies, fungal infection and worm infection were 16.67, 18.50, 15.67, 16, 19.17 and 14% respectively. Total money spent for the treatment of dysentery, ARI, diarrhea, fungal infection, scabies and worm infection was Tk. 33.33, 22.08, 11.24, 28.09, 4.30 and 0.96% respectively.Rational drug use and drug availability at the facilities were not satisfactory. Adequate drug funding to ensure availability of essential drugs is vital to improve the situation. The care provided to patients was insufficient. 

Author Biography

H. M. Alamgir, Department of Clinical Pharmacy and Pharmacology Faculty of Pharmacy University of Dhaka
Department of Clinical Pharmacy and Pharmacology Rank-1


[1] Brudon P, Rainhorn JD, Reich MR. Indicators for monitoring national drug policies: a practical manual. 2nd ed. Geneva: World Health Organization, 1999:17-29.
[2] Guyon AB, Barman A, Ahmed JU, Ahmed AU, Alam MS. A baseline survey on use of drugs at the primary health care level in Bangladesh. Bull World Health Organ 1994; 72:265-71.
[3] Islam MS. A review on the policy and practice of therapeutic drug uses in Bangladesh. Calicut Med J 2006; 4:e2.
[4] Chedi B.A.Z., Abdu-Ague, I., et al WHO Core prescription Indicators: Filed experience in public health facilities in Kano, Nigeria. 2004 BEST J.6 (3):66-70
[5] Ojaju-Obodo, J.O.,Isah , A.O.,et al, Prescribing patterns of Clinicians in private health institutions in Edo and Delta States of Nigeria, Niger Quart J. Hospital Med. 1998;8(2):91-94
[6] Isah A.O., Ross-Degnan , D., Quick J., et al, Developing Standard Values for WHO Drug prescribing Indicators,Geneva:WHO;2008.
[7] Hogerzeil,H.V.,Bimo, B.,Ofori-Adjei D., et al ,Field test for Rational Drug Use in twelve developing countries. Lancet 1993, 342(8884):1408-1410, 1993.